Cargando…

Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase

OBJECTIVES: To evaluate the pulmonary function in Guillain–Barre syndrome (GBS) patients in subacute phase and find clinical correlates of pulmonary dysfunction. METHODS: This was a single-center, prospective, cross-sectional, hospital-based study in GBS patients performed in Department of Neurologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Meeka, Rawat, Nidhi, Gupta, Anupam, Nagappa, Madhu, Taly, Arun B., Rukmani, M. R., Sathyaprabha, T. N., Haldar, Partha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488563/
https://www.ncbi.nlm.nih.gov/pubmed/28694622
http://dx.doi.org/10.4103/jnrp.jnrp_11_17
_version_ 1783246682681507840
author Khanna, Meeka
Rawat, Nidhi
Gupta, Anupam
Nagappa, Madhu
Taly, Arun B.
Rukmani, M. R.
Sathyaprabha, T. N.
Haldar, Partha
author_facet Khanna, Meeka
Rawat, Nidhi
Gupta, Anupam
Nagappa, Madhu
Taly, Arun B.
Rukmani, M. R.
Sathyaprabha, T. N.
Haldar, Partha
author_sort Khanna, Meeka
collection PubMed
description OBJECTIVES: To evaluate the pulmonary function in Guillain–Barre syndrome (GBS) patients in subacute phase and find clinical correlates of pulmonary dysfunction. METHODS: This was a single-center, prospective, cross-sectional, hospital-based study in GBS patients performed in Department of Neurological Rehabilitation at a tertiary care institute. Clinical examination for pulmonary function was done by measuring chest expansion. The pulmonary function tests were carried out by Spirometry kit Microquark Cosmed, Italy. Fatigue was assessed by Fatigue Severity Scale, disability status by Hughes Disability Scale (HDS), and muscle weakness by Medical Research Council sum scores. STATISTICAL ANALYSIS: Statistical analysis was performed by Stata 11. The significance of P value was adjudged against an alpha of 0.05. RESULTS: Twenty-eight patients were included with 17 (61%) men and mean age of 31 years. Median duration of symptoms was 16.5 days. There were 10 (36%) demyelinating and 18 (64%) axonal variants. Twenty-six (93%) patients scored more than 2 on HDS. All study participants reported fatigue. Twenty-two (78.6%) patients had chest expansion of <2.5 cm. Spirometry showed restrictive pulmonary dysfunction in 23 (79%) patients. Significant correlation was found between abnormal pulmonary function test and chest expansion (P = 0.003). CONCLUSION: Pulmonary dysfunction in GBS is common even during subacute phase. It needs to be identified and managed appropriately for better clinical outcome.
format Online
Article
Text
id pubmed-5488563
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54885632017-07-11 Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase Khanna, Meeka Rawat, Nidhi Gupta, Anupam Nagappa, Madhu Taly, Arun B. Rukmani, M. R. Sathyaprabha, T. N. Haldar, Partha J Neurosci Rural Pract Original Article OBJECTIVES: To evaluate the pulmonary function in Guillain–Barre syndrome (GBS) patients in subacute phase and find clinical correlates of pulmonary dysfunction. METHODS: This was a single-center, prospective, cross-sectional, hospital-based study in GBS patients performed in Department of Neurological Rehabilitation at a tertiary care institute. Clinical examination for pulmonary function was done by measuring chest expansion. The pulmonary function tests were carried out by Spirometry kit Microquark Cosmed, Italy. Fatigue was assessed by Fatigue Severity Scale, disability status by Hughes Disability Scale (HDS), and muscle weakness by Medical Research Council sum scores. STATISTICAL ANALYSIS: Statistical analysis was performed by Stata 11. The significance of P value was adjudged against an alpha of 0.05. RESULTS: Twenty-eight patients were included with 17 (61%) men and mean age of 31 years. Median duration of symptoms was 16.5 days. There were 10 (36%) demyelinating and 18 (64%) axonal variants. Twenty-six (93%) patients scored more than 2 on HDS. All study participants reported fatigue. Twenty-two (78.6%) patients had chest expansion of <2.5 cm. Spirometry showed restrictive pulmonary dysfunction in 23 (79%) patients. Significant correlation was found between abnormal pulmonary function test and chest expansion (P = 0.003). CONCLUSION: Pulmonary dysfunction in GBS is common even during subacute phase. It needs to be identified and managed appropriately for better clinical outcome. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5488563/ /pubmed/28694622 http://dx.doi.org/10.4103/jnrp.jnrp_11_17 Text en Copyright: © 2017 Journal of Neurosciences in Rural Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Khanna, Meeka
Rawat, Nidhi
Gupta, Anupam
Nagappa, Madhu
Taly, Arun B.
Rukmani, M. R.
Sathyaprabha, T. N.
Haldar, Partha
Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title_full Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title_fullStr Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title_full_unstemmed Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title_short Pulmonary Involvement in Patients with Guillain–Barré Syndrome in Subacute Phase
title_sort pulmonary involvement in patients with guillain–barré syndrome in subacute phase
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488563/
https://www.ncbi.nlm.nih.gov/pubmed/28694622
http://dx.doi.org/10.4103/jnrp.jnrp_11_17
work_keys_str_mv AT khannameeka pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT rawatnidhi pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT guptaanupam pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT nagappamadhu pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT talyarunb pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT rukmanimr pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT sathyaprabhatn pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase
AT haldarpartha pulmonaryinvolvementinpatientswithguillainbarresyndromeinsubacutephase